Researchers are trying to understand if semaglutides blood sugar-lowering effects are directly linked to changes in cortisol levels, or if they are due to other factors like improved insulin sensitivity and reduced appetite
Lilly recently completed a new hybrid peptide manufacturing facility at its existing site at Kinsale in Ireland, together with expansion in the US and Germany
Consumers using GLP-1 medications are seeking more products with protein, fiber and healthy fats while reducing purchases of products high in carbohydrates and sugar, creating potential implications across grocery aisles, pharmacies, product portfolios, merchandising strategies and shopper engagement
From 2004 to 2009, an analysis of the database revealed a six-fold increase in pancreatitis incidents linked to the DPP-4 inhibitor sitagliptin and the GLP-1 mimetic exenatide, the first two GLP-1-based medications marketed in the US [51]
For a detailed comparison of oral vs injectable semaglutide, see our [oral semaglutide vs injection guide](/guides/oral-semaglutide-vs-injection-wegovy-pill-guide-2026)
Long-term studies are needed to validate the potential cardioprotective effects of low dose GLP-1 in generally healthy individuals A Review on the Efficacy and Safety of Oral Semaglutide PMC What the evidence suggests: Low-dose Semaglutide may reduce the rate of major cardiovascular events and death in patients with metabolic disease
